China Universal Asset Management Co., Ltd. Kymera Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 13,027 shares of KYMR stock, worth $569,279. This represents 0.03% of its overall portfolio holdings.
Number of Shares
13,027
Previous 13,733
5.14%
Holding current value
$569,279
Previous $552,000
35.51%
% of portfolio
0.03%
Previous 0.05%
Shares
16 transactions
Others Institutions Holding KYMR
# of Institutions
177Shares Held
67.4MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$293 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$282 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$262 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$262 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$229 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.39B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...